Patents by Inventor Yongcong Tan

Yongcong Tan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TNFR2 BINDING MOLECULE AND USE THEREOF
    Publication number: 20250043016
    Abstract: The present invention relates to a specific TNFR2 binding molecule, an epitope peptide of TNFR2 that is bound to the TNFR2 binding molecule, and a composition containing same. The present invention also relates to a nucleic acid encoding the TNFR2 binding molecule, a host cell containing the nucleic acid, and a method for preparing the TNFR2 binding molecule. Furthermore, the present invention relates to the therapeutic and diagnostic use of the TNFR2 binding molecules. Particularly, the present invention relates to the combined treatment of the TNFR2 binding molecules with other therapies, such as therapeutic methods or therapeutic agents.
    Type: Application
    Filed: December 5, 2022
    Publication date: February 6, 2025
    Inventors: Guojun LANG, Chao KONG, Yuhao HU, Xiaoxiao SHI, Zhen ZHANG, Xintian YAN, Run YAN, Chanjuan LIU, Yongcong TAN
  • BISPECIFIC ANTIBODY AGAINST CD40 AND CLDN18.2 AND APPLICATION THEREOF
    Publication number: 20250026843
    Abstract: A bispecific antibody targeting both CD40 and CLDN18.2, a pharmaceutical composition comprising same, an application thereof for treating related diseases, and a treatment method are provided. The bispecific antibody targeting both CD40 and CLDN18.2 comprises (i) an anti-CD40 antibody or a fragment thereof and (ii) an anti-CLDN18.2 antibody or a fragment thereof.
    Type: Application
    Filed: December 28, 2022
    Publication date: January 23, 2025
    Applicant: ANHUI BIOX-VISION BIOLOGICAL TECHNOLOGY CO., LTD.
    Inventors: Guojun LANG, Wenhai ZHANG, Guoxing WANG, Run YAN, Zhen ZHANG, Yuhao HU, Peipei LIU, Li FAN, Yongcong TAN
  • CLDN18.2 BINDING MOLECULES AND USE THEREOF
    Publication number: 20240247060
    Abstract: The present invention relates to specific CLDN18.2 binding molecules, and an immunoconjugate and a composition containing the CLDN18.2 binding molecules. The present invention further relates to a nucleic acid encoding the CLDN18.2 binding molecules, a host cell containing same, and a method for preparing the CLDN18.2 binding molecules. Furthermore, the present invention relates to the therapeutic and diagnostic use of the CLDN18.2 binding molecules. In particular, the present invention relates to the combined treatment of the CLDN18.2 binding molecules with other therapies, such as a therapeutic method or a therapeutic agent.
    Type: Application
    Filed: July 13, 2022
    Publication date: July 25, 2024
    Inventors: Xintian YAN, Guojun LANG, Yongcong TAN, Chanjuan LIU, Chao KONG, Run YAN, Yaru LIU, Tianen YAO
  • Molecule Specifically Binding to CLDN18.2
    Publication number: 20240092891
    Abstract: Provided are a molecule specifically binding to CLDN18.2, the molecule comprising an immunoglobulin single variable domain, a nucleic acid molecule encoding the molecule specifically binding to CLDN18.2, and an expression vector and a host cell for expressing the molecule specifically binding to CLDN18.2; further provided are a method for producing the molecule specifically binding to CLDN18.2 and use thereof for treating or preventing conditions associated with CLDN18.2.
    Type: Application
    Filed: November 23, 2021
    Publication date: March 21, 2024
    Inventors: Yongcong Tan, Guojun Lang, Chanjuan Liu, Xintian Yan
  • NOVEL CLDN18.2 BINDING MOLECULE
    Publication number: 20220396616
    Abstract: Disclosed is a novel CLDN18.2 binding molecule. Also disclosed are a nucleic acid molecule encoding the CLDN18.2 binding molecule, an expression vector and a host cell for expressing the CLDN18.2 binding molecule. Further disclosed are a method for producing the CLDN18.2 binding molecule and use thereof.
    Type: Application
    Filed: May 21, 2020
    Publication date: December 15, 2022
    Inventors: Yongcong Tan, Guojun Lang, Chao Kong, Chanjuan Liu, Min Deng, Qi Wu, Jing Zhang, Wenhai Zhang, Baoguo Fan